Gene · 5300
Papers3,752
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,752
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers. | Clin Cancer Res | 2022 | 36048535 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy. | Pharmaceutics | 2022 | 36015374 | PubTator, text mining | PubMed |
| New Benzimidazoles Targeting Breast Cancer: Synthesis, Pin1 Inhibition, 2D NMR Binding, and Computational Studies. | Molecules | 2022 | 36014485 | PubTator, text mining | PubMed |
| Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects. | Int J Mol Sci | 2022 | 36012132 | PubTator, text mining | PubMed |
| Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer. | Int J Mol Sci | 2022 | 36012111 | PubTator, text mining | PubMed |
| Neutrophils, Fast and Strong. | Biomedicines | 2022 | 36009587 | PubTator, text mining | PubMed |
| Inhibition of the PIN1-NRF2/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 35983979 | PubTator, text mining | PubMed |
| Modeled microgravity alters apoptotic gene expression and caspase activity in the squid-vibrio symbiosis. | BMC Microbiol | 2022 | 35982413 | PubTator, text mining | PubMed |
| Five novel RB1 gene mutations and genotype-phenotype correlations in Chinese children with retinoblastoma. | Int Ophthalmol | 2022 | 35960463 | PubTator, text mining | PubMed |
| Regulation of Interleukin-36γ/IL-36R Signaling Axis by PIN1 in Epithelial Cell Transformation and Breast Tumorigenesis. | Cancers (Basel) | 2022 | 35954317 | PubTator, text mining | PubMed |
| Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance. | Cell Rep | 2022 | 35947955 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms. | Front Pharmacol | 2022 | 35935861 | PubTator, text mining | PubMed |
| The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence. | Discov Oncol | 2022 | 35933633 | PubTator, text mining | PubMed |
| Ligand-specific conformational change drives interdomain allostery in Pin1. | Nat Commun | 2022 | 35927276 | PubTator, text mining | PubMed |
| Protein PEGylation: Navigating Recombinant Protein Stability, Aggregation, and Bioactivity. | Biomed Res Int | 2022 | 35924267 | PubTator, text mining | PubMed |
| ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide. | Sci Rep | 2022 | 35922651 | PubTator, text mining | PubMed |
| 15N-Detected TROSY NMR experiments to study large disordered proteins in high-field magnets. | Chem Commun (Camb) | 2022 | 35920752 | PubTator, text mining | PubMed |
| Structural insights into auxin recognition and efflux by Arabidopsis PIN1. | Nature | 2022 | 35917925 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5300/papers?page=32